comparemela.com

Latest Breaking News On - Hikma pharmaceuticals stock performance - Page 1 : comparemela.com

Hikma Pharmaceuticals PLC (LON:HIK) Receives Consensus Rating of Moderate Buy from Analysts

Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) has been given an average rating of “Moderate Buy” by the six brokerages that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among […]

Hikma Pharmaceuticals (HIK) Equal Weight Rating Reaffirmed at Barclays

Hikma Pharmaceuticals (HIK) Equal Weight Rating Reaffirmed at Barclays
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hikma Pharmaceuticals PLC (LON:HIK) Given Consensus Recommendation of Moderate Buy by Brokerages

Hikma Pharmaceuticals PLC (LON:HIK) Given Consensus Recommendation of Moderate Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Brokerages Set Hikma Pharmaceuticals PLC (LON:HIK) Price Target at GBX 2,068 75

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective […]

Hikma Pharmaceuticals PLC (LON:HIK) Receives Consensus Recommendation of Moderate Buy from Analysts

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.